speb/financial-data huggingface dataset:
Financial ratios for SNY — annual report dated 2025-12-31
Total revenue: 54960000000
Gross profit: 39608235294.117645
Operating income: 11290588235.294119
Net income: 9236470588.235294
Capital expenditures: 3165882352.9411764
Operating cash flow: 12647058823.529411
Depreciation & amortization: 6680000000
Net tangible assets: 4488235294.117647
Owner earnings: 12750588235.294117
Return on net tangible assets (%): 284.08912188728704
Capex to operating income (%): 28.04001250390747
Buffett classification: The Good
Stock price: 45.91
P/E ratio: 11.898260805771365
Shares outstanding: 2393769026
Book value: 84364705882.35295
P/B ratio: 1.3026529854429085
Market cap (USD): 109897935983.65999
Debt to equity: 0.28348905313066514
Current ratio: 1.09197389310284
Quick ratio: 0.7316281531134239
Effective tax rate (%): 16.890688259109314
Interest coverage ratio: 15.330670926517573
COGS to revenue (%): 27.932614093672402
R&D to revenue (%): 16.786539943488314
SG&A to revenue (%): 21.923966092987417
Free cash flow (dilution-adjusted): 8484705882.3529415
Buyback yield (%): 5.384675340675539
Inventory turnover: 1.2775602114744469
Receivables turnover: 4.229223248234655
Capitalized R&D asset: 16772178186.274511
ROCI (R&D-adjusted, %): 9.399029438485524
Rosenberg metric: 0.9389918694012629
FCF margin (%): 15.4379655792448
Revenue growth (%): 19.13832813981845
Rule of 40 score: 34.57629371906325
Financial ratios for TBLA — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 30104000
Buffett classification: The Gruesome
Stock price: 7.78
Shares outstanding: 243284708
Market cap (USD): 1892755028.24
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TBLA — annual report dated 2022-12-31
Total revenue: 1401150000
Gross profit: 464253000
Operating income: -13665000
Net income: -11975000
Capital expenditures: 34914000
Operating cash flow: 53484000
Depreciation & amortization: 91221000
Net tangible assets: 89510000
Owner earnings: 44332000
Buffett classification: The Gruesome
Stock price: 3.08
Shares outstanding: 243284708
Book value: 834535000
P/B ratio: 0.8978855298339794
Market cap (USD): 749316900.64
Debt to equity: 0.3579598219367672
Current ratio: 1.61290743084335
Quick ratio: 1.61290743084335
COGS to revenue (%): 66.86628840595226
R&D to revenue (%): 9.226421154052028
SG&A to revenue (%): 24.88256075366663
Free cash flow (dilution-adjusted): -56351000
Buyback yield (%): 0
Retained earnings: -68420000
Receivables turnover: 5.458146999703944
Capitalized R&D asset: 129276000
ROCI (R&D-adjusted, %): 5.6186791892936805
FCF margin (%): -4.021767833565286
Rule of 40 score: -4.021767833565286
Financial ratios for TBLA — annual report dated 2023-12-31
Total revenue: 1439685000
Gross profit: 425558000
Operating income: -63737000
Net income: -82040000
Capital expenditures: 32133000
Operating cash flow: 84373000
Depreciation & amortization: 96512000
Net tangible assets: 375873000
Owner earnings: -17661000
Return on net tangible assets (%): -4.698661515990773
Buffett classification: The Gruesome
Stock price: 4.33
Shares outstanding: 243284708
Book value: 1057062000
P/B ratio: 0.9965572366048538
Market cap (USD): 1053422785.64
Debt to equity: 0.20327852103282495
Current ratio: 1.3194768436073732
Quick ratio: 1.3194768436073732
COGS to revenue (%): 70.44089505690481
R&D to revenue (%): 9.464223076575779
SG&A to revenue (%): 24.522030860917493
Free cash flow (dilution-adjusted): -12091000
Buyback yield (%): 5.26977399357025
Retained earnings: -150460000
Receivables turnover: 4.700137443806377
Capitalized R&D asset: 222869920
ROCI (R&D-adjusted, %): -1.0614096956117602
Rosenberg metric: -0.2993208329465639
FCF margin (%): -0.839836492010405
Revenue growth (%): 2.7502408735681403
Rule of 40 score: 1.9104043815577354
Financial ratios for TBLA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.36
Shares outstanding: 243284708
Market cap (USD): 817436618.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TBLA — annual report dated 2024-12-31
Total revenue: 1766220000
Gross profit: 534218000
Operating income: 25917000
Net income: -3760000
Capital expenditures: 35155000
Operating cash flow: 184331000
Depreciation & amortization: 100928000
Net tangible assets: 430908000
Owner earnings: 62013000
Capex to operating income (%): 135.6445576262685
Buffett classification: The Gruesome
Stock price: 3.65
Shares outstanding: 243284708
Book value: 1051906000
P/B ratio: 0.8441716124824842
Market cap (USD): 887989184.1999999
Debt to equity: 0.17196783743034075
Current ratio: 1.3509582315654205
Quick ratio: 1.3509582315654205
Effective tax rate (%): 126.9785463155629
COGS to revenue (%): 69.75359807951445
R&D to revenue (%): 8.064567267950764
SG&A to revenue (%): 20.71446365684909
Free cash flow (dilution-adjusted): 82078000
Buyback yield (%): 8.307195775864948
Retained earnings: -154220000
Receivables turnover: 4.772148820620896
Capitalized R&D asset: 276389930
ROCI (R&D-adjusted, %): 2.1441579230167416
Rosenberg metric: 0.7974753220065318
FCF margin (%): 4.64709945533399
Revenue growth (%): 22.68100313610269
Rule of 40 score: 27.32810259143668
Financial ratios for TBLA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.65
Shares outstanding: 243284708
Market cap (USD): 887989184.1999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TBLA — quarterly report dated 2025-03-31
Total revenue: 427493000
Gross profit: 119307000
Operating income: -6262000
Net income: -8750000
Capital expenditures: 12041000
Operating cash flow: 48111000
Depreciation & amortization: 20682000
Net tangible assets: 400958000
Owner earnings: -109000
Return on net tangible assets (%): -0.027184892183221183
Buffett classification: The Gruesome
Stock price: 2.95
Shares outstanding: 243284708
Book value: 1008209000
P/B ratio: 0.7118463419786969
Market cap (USD): 717689888.6
Debt to equity: 0.21173784403828969
Current ratio: 1.3216441138063755
Quick ratio: 1.3216441138063755
Interest coverage ratio: -1.3915555555555557
COGS to revenue (%): 72.09147284283017
R&D to revenue (%): 8.410897956223845
SG&A to revenue (%): 20.962448507928784
Free cash flow (dilution-adjusted): 20553000
Buyback yield (%): 7.203250431860689
Retained earnings: -162970000
Receivables turnover: 1.4020117147785933
Capitalized R&D asset: 35956000
ROCI (R&D-adjusted, %): 1.4172954004194314
FCF margin (%): 4.807798022423759
Rule of 40 score: 4.807798022423759
Financial ratios for TBLA — quarterly report dated 2025-06-30
Total revenue: 465474000
Gross profit: 135611000
Operating income: 44000
Net income: -4345000
Capital expenditures: 13236000
Operating cash flow: 47397000
Depreciation & amortization: 23705000
Net tangible assets: 331529000
Owner earnings: 6124000
Capex to operating income (%): 30081.81818181818
Buffett classification: The Gruesome
Stock price: 3.66
Shares outstanding: 243284708
Book value: 925033000
P/B ratio: 0.9625840713574543
Market cap (USD): 890422031.2800001
Debt to equity: 0.18966890910918854
Current ratio: 1.074969715289631
Quick ratio: 1.074969715289631
COGS to revenue (%): 70.86604192715382
R&D to revenue (%): 8.052436870802666
SG&A to revenue (%): 21.072068472138078
Free cash flow (dilution-adjusted): 17589000
Buyback yield (%): 11.384601507925078
Retained earnings: -167315000
Receivables turnover: 1.5737275929920413
Capitalized R&D asset: 61572520
ROCI (R&D-adjusted, %): 1.134332447788915
Rosenberg metric: 0.4534430971187006
FCF margin (%): 3.7787287796955358
Revenue growth (%): 8.884589923109852
Rule of 40 score: 12.663318702805388
Financial ratios for TBLA — quarterly report dated 2025-09-30
Total revenue: 496764000
Gross profit: 139019000
Operating income: 6505000
Net income: 5244000
Capital expenditures: 6914000
Operating cash flow: 53203000
Depreciation & amortization: 20441000
Net tangible assets: 330519000
Owner earnings: 18771000
Return on net tangible assets (%): 5.679249906964501
Capex to operating income (%): 106.28747117601844
Buffett classification: The Gruesome
Stock price: 3.41
P/E ratio: 39.5500025877193
Shares outstanding: 243284708
Book value: 911462000
P/B ratio: 0.9101869900006803
Market cap (USD): 829600854.2800001
Debt to equity: 0.18501703856002774
Current ratio: 1.0554949026538802
Quick ratio: 1.0554949026538802
Effective tax rate (%): 25.13918629550321
COGS to revenue (%): 72.01508160816806
R&D to revenue (%): 7.622734336626648
SG&A to revenue (%): 19.052709133512092
Free cash flow (dilution-adjusted): 30575000
Buyback yield (%): 4.027237897313415
Retained earnings: -162071000
Receivables turnover: 1.6081709291032698
Capitalized R&D asset: 74845420
ROCI (R&D-adjusted, %): 0.6388870908503186
Rosenberg metric: 0.09092364334880743
FCF margin (%): 6.154834086205925
Revenue growth (%): 6.7221799713840085
Rule of 40 score: 12.877014057589934
Financial ratios for TBLA — annual report dated 2025-12-31
Total revenue: 1912040000
Gross profit: 569510000
Operating income: 44057000
Net income: 42284000
Capital expenditures: 44918000
Operating cash flow: 208364000
Depreciation & amortization: 83484000
Net tangible assets: 337339000
Owner earnings: 80850000
Return on net tangible assets (%): 23.966988696830192
Capex to operating income (%): 101.95428649249835
Buffett classification: The Gruesome
Stock price: 4.61
P/E ratio: 26.52403991769937
Shares outstanding: 243284708
Book value: 907195000
P/B ratio: 1.2362750057925804
Market cap (USD): 1121542503.88
Debt to equity: 0.21394518267847595
Current ratio: 1.0711466775183025
Quick ratio: 1.0711466775183025
Effective tax rate (%): -29.05234243857775
COGS to revenue (%): 70.21453526076861
R&D to revenue (%): 7.742725047593146
SG&A to revenue (%): 19.738551494738605
Free cash flow (dilution-adjusted): 99510000
Buyback yield (%): 22.85343614827674
Retained earnings: -111936000
Receivables turnover: 5.308774287411915
Capitalized R&D asset: 288441610
ROCI (R&D-adjusted, %): 3.6197491097065577
Rosenberg metric: 0.24777095999663012
FCF margin (%): 5.204389029518211
Revenue growth (%): 8.256049642739862
Rule of 40 score: 13.460438672258073
Financial ratios for TBLA — quarterly report dated 2025-12-31
Total revenue: 522309000
Gross profit: 175573000
Operating income: 43770000
Net income: 50135000
Capital expenditures: 12727000
Operating cash flow: 59653000
Depreciation & amortization: 18656000
Net tangible assets: 337339000
Owner earnings: 56064000
Return on net tangible assets (%): 16.619483664800097
Capex to operating income (%): 29.076993374457388
Buffett classification: The Good
Stock price: 4.61
P/E ratio: 26.52403991769937
Shares outstanding: 243284708
Book value: 907195000
P/B ratio: 1.2362750057925804
Market cap (USD): 1121542503.88
Debt to equity: 0.21394518267847595
Current ratio: 1.0711466775183025
Quick ratio: 1.0711466775183025
Effective tax rate (%): -28.653545125612666
COGS to revenue (%): 66.38522407234032
R&D to revenue (%): 7.033958825139908
SG&A to revenue (%): 18.200720263292418
Free cash flow (dilution-adjusted): 30793000
Buyback yield (%): 6.226513909050371
Retained earnings: -111936000
Receivables turnover: 1.4501896347795182
Capitalized R&D asset: 74478950
ROCI (R&D-adjusted, %): 3.708794516855655
Rosenberg metric: 0.9653260094541422
FCF margin (%): 5.895552249721908
Revenue growth (%): 5.14228084160688
Rule of 40 score: 11.037833091328789
Financial ratios for TRIGYN.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.7737043386522484
Shares outstanding: 30785736
Market cap (USD): 54604793.51180272
Buyback yield (%): 0
Retained earnings: 48157206.91019385
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRIGYN.NS — annual report dated 2023-03-31
Total revenue: 155021242.38733253
Gross profit: 52554336.17539586
Operating income: 6796272.838002437
Net income: 4223775.883069428
Capital expenditures: 680194.8842874544
Operating cash flow: -6342570.036540804
Depreciation & amortization: 828489.646772229
Net tangible assets: 71122545.67600487
Owner earnings: 4372070.645554203
Return on net tangible assets (%): 6.1472358785791315
Capex to operating income (%): 10.008351643624971
Buffett classification: The Great
Stock price: 1.1193666260657735
P/E ratio: 8.15870121693793
Shares outstanding: 30785736
Book value: 82947064.55542022
P/B ratio: 0.41545201897105327
Market cap (USD): 34460525.437271625
Debt to equity: 0.009959979171665476
Current ratio: 3.363933396933187
Quick ratio: 3.2994291252785035
Effective tax rate (%): 40.452992186829235
Interest coverage ratio: 53.86369340669949
COGS to revenue (%): 66.0986227654628
SG&A to revenue (%): 24.702355042458528
Free cash flow (dilution-adjusted): -7022764.920828259
Buyback yield (%): 0
Retained earnings: 48676309.37880634
Inventory turnover: 79.50077019760529
Receivables turnover: 4.179508878535824
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.062786310889518
FCF margin (%): -4.530195225297795
Rule of 40 score: -4.530195225297795
Financial ratios for TRIGYN.NS — annual report dated 2024-03-31
Total revenue: 153455126.5139705
Gross profit: 56794076.028300755
Operating income: 3544969.42079386
Net income: 2393968.10169085
Capital expenditures: 90454.49094615661
Operating cash flow: 15104868.689291282
Depreciation & amortization: 824667.2262861255
Net tangible assets: 72695131.31070872
Owner earnings: 3128180.837030819
Return on net tangible assets (%): 4.303150404475584
Capex to operating income (%): 2.551629653434366
Buffett classification: The Great
Stock price: 1.1192418426103647
P/E ratio: 14.393125732301788
Shares outstanding: 30785736
Book value: 84088439.86089459
P/B ratio: 0.4097671920629884
Market cap (USD): 34456683.88675624
Debt to equity: 0.006699813965361477
Current ratio: 4.255793166340441
Quick ratio: 4.208601393977728
Effective tax rate (%): 47.75454978461474
Interest coverage ratio: 29.941760356527908
COGS to revenue (%): 62.98978253872135
SG&A to revenue (%): 26.77823672698649
Free cash flow (dilution-adjusted): 15014414.198345125
Buyback yield (%): 0
Retained earnings: 50264779.94963425
Inventory turnover: 106.54090170109839
Receivables turnover: 5.137580155356457
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.14390508191367
FCF margin (%): 9.784237607062424
Revenue growth (%): -1.0102588840366622
Rule of 40 score: 8.773978723025762
Financial ratios for TRIGYN.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 73987326.80363116
Buffett classification: The Gruesome
Stock price: 1.6372431915910177
Shares outstanding: 30785736
Book value: 85056103.67892978
P/B ratio: 0.5925939995368561
Market cap (USD): 50403736.66411849
Debt to equity: 0.005830164373954573
Current ratio: 5.004356484753051
Quick ratio: 4.930971528967786
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TRIGYN.NS — annual report dated 2025-03-31
Total revenue: 104955669.86205283
Gross profit: 48430406.827215336
Operating income: 1672270.2829085807
Net income: 1375917.6993219545
Capital expenditures: 14835.164835164835
Operating cash flow: 6019698.386719663
Depreciation & amortization: 585667.5239653962
Net tangible assets: 75923871.87280804
Owner earnings: 1946750.058452186
Return on net tangible assets (%): 2.564081639189176
Capex to operating income (%): 0.8871272178180446
Buffett classification: The Great
Stock price: 0.7899404831368888
P/E ratio: 17.674675732094258
Shares outstanding: 30785736
Book value: 86632733.22422259
P/B ratio: 0.2807125928558967
Market cap (USD): 24318899.16956471
Debt to equity: 0.01721825761170135
Current ratio: 4.815021084522597
Quick ratio: 4.755938294680604
Effective tax rate (%): 52.032306175405864
Interest coverage ratio: 5.16038961038961
COGS to revenue (%): 53.8563215394945
SG&A to revenue (%): 39.96322974127157
Free cash flow (dilution-adjusted): 6004863.221884498
Buyback yield (%): 0
Retained earnings: 50340858.07809212
Inventory turnover: 54.70826308822032
Receivables turnover: 3.6846168747168173
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8975800766694195
FCF margin (%): 5.721332853934347
Revenue growth (%): -31.60497648640125
Rule of 40 score: -25.883643632466903
Financial ratios for TRIGYN.NS — quarterly report dated 2025-03-31
Total revenue: 28112415.244330134
Gross profit: 13652735.562310029
Operating income: 508311.9008650923
Net income: 299018.0032733224
Capital expenditures: 0
Depreciation & amortization: 145382.2772971709
Net tangible assets: 75923871.87280804
Owner earnings: 444400.2805704933
Return on net tangible assets (%): 0.5853235215861723
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.7899404831368888
P/E ratio: 20.332303492890038
Shares outstanding: 30785736
Book value: 86632733.22422259
P/B ratio: 0.2807125928558967
Market cap (USD): 24318899.16956471
Debt to equity: 0.01721825761170135
Current ratio: 4.815021084522597
Quick ratio: 4.755938294680604
Effective tax rate (%): 56.27977383019456
Interest coverage ratio: 2.3109752856763217
COGS to revenue (%): 51.43520951988078
Buyback yield (%): 0
Retained earnings: 50340858.07809212
Inventory turnover: 13.9948744639685
Receivables turnover: 0.9869260015628385
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.5767982279383067
Rule of 40 score: 0
Financial ratios for TRIGYN.NS — quarterly report dated 2025-06-30
Total revenue: 26269588.111397147
Gross profit: 12168417.973320853
Operating income: -373028.3173414463
Net income: -539269.8338403932
Capital expenditures: 0
Depreciation & amortization: 90720.8050549965
Owner earnings: -448549.0287853967
Buffett classification: The Gruesome
Stock price: 0.9970746548092675
Shares outstanding: 30785736
Market cap (USD): 30695677.09524924
Effective tax rate (%): 721.0467550593161
Interest coverage ratio: -5.95201643017177
COGS to revenue (%): 53.678687607433226
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -6.555207430299531
Rule of 40 score: -6.555207430299531
Financial ratios for TRIGYN.NS — quarterly report dated 2025-09-30
Total revenue: 27277497.18151071
Gross profit: 13330011.27395716
Operating income: 150124.0135287486
Net income: 594374.2953776775
Capital expenditures: 0
Depreciation & amortization: 97204.05862457723
Net tangible assets: 75590259.30101465
Owner earnings: 691578.3540022548
Return on net tangible assets (%): 0.9149040635622898
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 0.9683201803833145
P/E ratio: 84.18118701589985
Shares outstanding: 30785736
Book value: 85854295.37767756
P/B ratio: 0.347221409314646
Market cap (USD): 29810449.436753098
Debt to equity: 0.008853126268831227
Current ratio: 5.2473143844155885
Quick ratio: 5.183962429668417
Effective tax rate (%): -10.977396400167432
Interest coverage ratio: 2.114657773542957
COGS to revenue (%): 51.13183887342665
Buyback yield (%): 0
Inventory turnover: 13.984378179187484
Receivables turnover: 0.9076511983589971
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.17147973645485864
Revenue growth (%): 3.8367905345127102
Rule of 40 score: 3.8367905345127102
Financial ratios for TRIGYN.NS — quarterly report dated 2025-12-31
Total revenue: 28743667.149381753
Gross profit: 15048646.541160746
Operating income: -61913.779659128886
Net income: 76996.76952211207
Capital expenditures: 0
Depreciation & amortization: 79837.36214771082
Owner earnings: 156834.1316698229
Buffett classification: The Gruesome
Stock price: 0.7455720173777433
P/E ratio: 53.24045291438915
Shares outstanding: 30785736
Market cap (USD): 22952983.295978617
Effective tax rate (%): 57.69734789391576
Interest coverage ratio: -1.2004319654427644
COGS to revenue (%): 47.6453492765817
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 5.375016476456081
Rule of 40 score: 5.375016476456081
Financial ratios for VRA — annual report dated 2022-01-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 8.19
Shares outstanding: 28438252
Market cap (USD): 232909283.88
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRA — annual report dated 2023-01-31
Total revenue: 499961000
Gross profit: 238944000
Operating income: -24215000
Net income: -59735000
Capital expenditures: 8239000
Operating cash flow: -13421000
Depreciation & amortization: 33700000
Net tangible assets: 235460000
Owner earnings: -34274000
Return on net tangible assets (%): -14.556187887539284
Buffett classification: The Gruesome
Stock price: 5.95
Shares outstanding: 28438252
Book value: 262090000
P/B ratio: 0.6456087580602083
Market cap (USD): 169207599.4
Debt to equity: 0.3600976763707123
Current ratio: 3.348685280163176
Quick ratio: 1.2457986608924427
Interest coverage ratio: -158.26797385620915
COGS to revenue (%): 52.20747218283026
SG&A to revenue (%): 52.727312730392974
Free cash flow (dilution-adjusted): -24901000
Buyback yield (%): 10.674461468661436
Retained earnings: 274629000
Inventory turnover: 1.8345949745211738
Receivables turnover: 21.35125555175948
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -7.188787688069255
FCF margin (%): -4.9805884859019
Rule of 40 score: -4.9805884859019
Financial ratios for VRA — annual report dated 2024-01-31
Total revenue: 383713000
Gross profit: 203965000
Operating income: 11617000
Net income: 7838000
Capital expenditures: 3770000
Operating cash flow: 47993000
Depreciation & amortization: 31905000
Net tangible assets: 252356000
Owner earnings: 35973000
Return on net tangible assets (%): 14.254862178826736
Capex to operating income (%): 32.45244038908496
Buffett classification: The Good
Stock price: 7.68
P/E ratio: 27.864987925491196
Shares outstanding: 28438252
Book value: 259929000
P/B ratio: 0.8402516662627102
Market cap (USD): 218405775.35999998
Debt to equity: 0.31163894755875643
Current ratio: 3.8783577350199963
Quick ratio: 1.8482175039906628
Effective tax rate (%): 29.98859749144812
COGS to revenue (%): 46.84438629913503
SG&A to revenue (%): 50.36238021646386
Free cash flow (dilution-adjusted): 41281000
Buyback yield (%): 1.0036364635444777
Retained earnings: 282467000
Inventory turnover: 1.5197078070308934
Receivables turnover: 21.835372446366584
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.601891326253779
FCF margin (%): 10.75830112610206
Revenue growth (%): -23.2514136102616
Rule of 40 score: -12.493112484159541
Financial ratios for VRA — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.01
Shares outstanding: 28438252
Market cap (USD): 142475642.51999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VRA — quarterly report dated 2025-01-31
Total revenue: 99964000
Gross profit: 44960000
Operating income: -14487000
Net income: -46973000
Capital expenditures: 4323000
Operating cash flow: 21655000
Depreciation & amortization: 7901000
Net tangible assets: 178955000
Owner earnings: -43395000
Return on net tangible assets (%): -24.24911290547903
Buffett classification: The Gruesome
Stock price: 3.74
Shares outstanding: 28438252
Book value: 178955000
P/B ratio: 0.5943341201978152
Market cap (USD): 106359062.48
Debt to equity: 0.4768293705121399
Current ratio: 2.8429638059765834
Quick ratio: 1.266394219992068
COGS to revenue (%): 55.02380857108559
SG&A to revenue (%): 59.60145652434876
Free cash flow (dilution-adjusted): 15925000
Buyback yield (%): 0.5500236522957361
Retained earnings: 220279000
Inventory turnover: 0.601596850049218
Receivables turnover: 6.951116055907099
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -5.825160737765232
FCF margin (%): 15.930735064623263
Rule of 40 score: 15.930735064623263
Financial ratios for VRA — annual report dated 2025-01-31
Total revenue: 318795000
Gross profit: 158838000
Operating income: -26392000
Net income: -62188000
Capital expenditures: 10373000
Operating cash flow: -14102000
Depreciation & amortization: 30297000
Net tangible assets: 178955000
Owner earnings: -42264000
Return on net tangible assets (%): -23.617110446760357
Buffett classification: The Gruesome
Stock price: 3.74
Shares outstanding: 28438252
Book value: 178955000
P/B ratio: 0.5943341201978152
Market cap (USD): 106359062.48
Debt to equity: 0.4768293705121399
Current ratio: 2.8429638059765834
Quick ratio: 1.266394219992068
COGS to revenue (%): 50.175504634639815
SG&A to revenue (%): 58.36415251180226
Free cash flow (dilution-adjusted): -28151000
Buyback yield (%): 20.462760288144278
Retained earnings: 220279000
Inventory turnover: 1.7495023515257575
Receivables turnover: 22.167790835129686
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.612110318982538
FCF margin (%): -8.830439624209916
Revenue growth (%): -16.918373888817946
Rule of 40 score: -25.748813513027862
Financial ratios for VRA — quarterly report dated 2025-04-30
Total revenue: 51652000
Gross profit: 22767000
Operating income: -17857000
Net income: -33460000
Capital expenditures: 1871000
Operating cash flow: -17902000
Depreciation & amortization: 7516000
Net tangible assets: 146034000
Owner earnings: -27815000
Return on net tangible assets (%): -19.04693427557966
Buffett classification: The Gruesome
Stock price: 1.95
Shares outstanding: 28438252
Book value: 146034000
P/B ratio: 0.37973753646411107
Market cap (USD): 55454591.4
Debt to equity: 0.5540696002300834
Current ratio: 2.2779691780246374
Quick ratio: 0.6116498327815404
COGS to revenue (%): 55.92232633779912
SG&A to revenue (%): 78.99790908386896
Free cash flow (dilution-adjusted): -20527000
Buyback yield (%): 0
Retained earnings: 186819000
Inventory turnover: 0.2913233351151274
Receivables turnover: 3.464019851116625
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.567097012526567
FCF margin (%): -39.740958723766745
Revenue growth (%): -48.32939858349006
Rule of 40 score: -88.07035730725681
Financial ratios for VRA — quarterly report dated 2025-07-31
Total revenue: 70858000
Gross profit: 35497000
Operating income: -4592000
Net income: -4672000
Capital expenditures: 742000
Operating cash flow: -5396000
Depreciation & amortization: 6804000
Net tangible assets: 140486000
Owner earnings: 1390000
Buffett classification: The Gruesome
Stock price: 1.93
Shares outstanding: 28438252
Book value: 140486000
P/B ratio: 0.3906853804649573
Market cap (USD): 54885826.36
Debt to equity: 0.6102600970915252
Current ratio: 2.433182038666759
Quick ratio: 0.758228812972074
COGS to revenue (%): 49.904033418950576
SG&A to revenue (%): 57.074712805893476
Free cash flow (dilution-adjusted): -5355000
Buyback yield (%): 0
Retained earnings: 182147000
Inventory turnover: 0.3657340849149299
Receivables turnover: 4.065989556435416
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.2029052251837355
FCF margin (%): -7.557368257642044
Revenue growth (%): 37.1834585301634
Rule of 40 score: 29.626090272521356
Financial ratios for VRA — quarterly report dated 2025-10-31
Total revenue: 62253000
Gross profit: 26186000
Operating income: -12174000
Net income: -12365000
Capital expenditures: 452000
Operating cash flow: -4003000
Depreciation & amortization: 6808000
Net tangible assets: 128063000
Owner earnings: -6009000
Return on net tangible assets (%): -4.6922217970842475
Buffett classification: The Gruesome
Stock price: 2.35
Shares outstanding: 28438252
Book value: 128063000
P/B ratio: 0.5218516839368125
Market cap (USD): 66829892.2
Debt to equity: 0.6747694494116178
Current ratio: 2.51632145134418
Quick ratio: 0.8103749717177119
COGS to revenue (%): 57.93616371901755
SG&A to revenue (%): 62.1174883138162
Free cash flow (dilution-adjusted): -4397000
Buyback yield (%): 0
Retained earnings: 169782000
Inventory turnover: 0.4348670090911283
Receivables turnover: 3.215879739642525
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.24093260264422
FCF margin (%): -7.063113424252647
Revenue growth (%): -12.144006322504165
Rule of 40 score: -19.20711974675681
Financial ratios for VRA — annual report dated 2026-01-31
Total revenue: 269651000
Gross profit: 125037000
Operating income: -30912000
Net income: -47840000
Capital expenditures: 3290000
Operating cash flow: -9971000
Depreciation & amortization: 27993000
Net tangible assets: 131639000
Owner earnings: -23137000
Return on net tangible assets (%): -17.576098268750144
Buffett classification: The Gruesome
Stock price: 2.4
Shares outstanding: 28438252
Book value: 131639000
P/B ratio: 0.5184770835390727
Market cap (USD): 68251804.8
Debt to equity: 0.5358138545567803
Current ratio: 2.3730624380574827
Quick ratio: 0.867591674925669
Interest coverage ratio: -66.9090909090909
COGS to revenue (%): 53.63006256234911
SG&A to revenue (%): 58.27606795450415
Free cash flow (dilution-adjusted): -14131000
Buyback yield (%): 0
Retained earnings: 172439000
Inventory turnover: 1.9040433964003107
Receivables turnover: 15.305426268588944
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.840728936830924
FCF margin (%): -5.24047750610975
Revenue growth (%): -15.415549177371037
Rule of 40 score: -20.65602668348079
Financial ratios for VRA — quarterly report dated 2026-01-31
Total revenue: 84888000
Gross profit: 40587000
Operating income: 3711000
Net income: 2657000
Capital expenditures: 225000
Operating cash flow: 17330000
Depreciation & amortization: 6865000
Net tangible assets: 131639000
Owner earnings: 9297000
Return on net tangible assets (%): 7.062496676516837
Capex to operating income (%): 6.063055780113177
Buffett classification: The Great
Stock price: 2.4
P/E ratio: 6.421886036883703
Shares outstanding: 28438252
Book value: 131639000
P/B ratio: 0.5184770835390727
Market cap (USD): 68251804.8
Debt to equity: 0.5358138545567803
Current ratio: 2.3730624380574827
Quick ratio: 0.867591674925669
Effective tax rate (%): -5.688146380270485
COGS to revenue (%): 52.18758835171049
SG&A to revenue (%): 43.85307699557063
Free cash flow (dilution-adjusted): 16148000
Buyback yield (%): 0
Retained earnings: 172439000
Inventory turnover: 0.583283959394873
Receivables turnover: 4.818254058349416
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.021737353926616
FCF margin (%): 19.022712279709737
Revenue growth (%): 36.35969350874657
Rule of 40 score: 55.3824057884563
Financial ratios for WCT — annual report dated 2024-12-31
Total revenue: 297579.63917525776
Gross profit: 208406.44329896907
Operating income: -56641.75257731959
Net income: -55611.34020618557
Capital expenditures: 0
Operating cash flow: -40737.886597938144
Depreciation & amortization: 38731.572164948455
Net tangible assets: 89269.32989690722
Owner earnings: -16879.768041237112
Return on net tangible assets (%): -18.908810070301556
Buffett classification: The Gruesome
Stock price: 48
Shares outstanding: 2905328
Book value: 633086.469072165
P/B ratio: 220.27914165403456
Market cap (USD): 139455744
Debt to equity: 0.12248005241869576
Current ratio: 1.0437680301015106
Quick ratio: 1.0437680301015106
Interest coverage ratio: -25.687569399801298
COGS to revenue (%): 29.96616170495813
SG&A to revenue (%): 72.52165018634012
Free cash flow (dilution-adjusted): -405701.15979381447
Buyback yield (%): 0
Retained earnings: 153194.20103092783
Receivables turnover: 1.7380235216905031
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.481066367614885
FCF margin (%): -136.3336419515178
Revenue growth (%): -6.662584384355666
Rule of 40 score: -142.99622633587344
Financial ratios for WCT — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 89269.32989690722
Buffett classification: The Gruesome
Stock price: 48
Shares outstanding: 2905328
Book value: 633086.469072165
P/B ratio: 220.27914165403456
Market cap (USD): 139455744
Debt to equity: 0.12248005241869576
Current ratio: 1.0437680301015106
Quick ratio: 1.0437680301015106
Buyback yield (%): 0
Retained earnings: 153194.20103092783
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WVM.V — annual report dated 2021-12-31
Capital expenditures: 247312.59842519683
Buffett classification: The Gruesome
Stock price: 0.8031496062992126
Shares outstanding: 58075566
Market cap (USD): 46643367.96850394
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WVM.V — annual report dated 2022-12-31
Total revenue: 0
Gross profit: 0
Operating income: -616280.1470588235
Net income: -1339562.5
Capital expenditures: 0
Operating cash flow: -557311.0294117647
Depreciation & amortization: 0
Net tangible assets: 31991246.32352941
Owner earnings: -1339562.5
Return on net tangible assets (%): -4.1872782524723275
Buffett classification: The Gruesome
Stock price: 0.6470588235294117
Shares outstanding: 58075566
Book value: 31991246.323529407
P/B ratio: 1.1746434331358337
Market cap (USD): 37578307.4117647
Debt to equity: 0
Current ratio: 15.121978040129976
Quick ratio: 15.121978040129976
Interest coverage ratio: -0.9015254514398316
Free cash flow (dilution-adjusted): -1011616.9117647058
Buyback yield (%): 0.5666050519578076
Retained earnings: -29857711.029411763
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.568862722448086
Rule of 40 score: 0
Financial ratios for WVM.V — annual report dated 2023-12-31
Total revenue: 0
Gross profit: -2540.909090909091
Operating income: -757006.8181818181
Net income: -1275055.303030303
Capital expenditures: 579858.3333333333
Operating cash flow: -358022.72727272724
Depreciation & amortization: 2540.909090909091
Net tangible assets: 30721303.030303027
Owner earnings: -1852372.727272727
Return on net tangible assets (%): -6.029603384483968
Buffett classification: The Gruesome
Stock price: 0.7196969696969696
Shares outstanding: 58075566
Book value: 30788531.060606062
P/B ratio: 1.3575447552649043
Market cap (USD): 41796808.86363636
Debt to equity: 0
Current ratio: 18.16951240363094
Quick ratio: 18.16951240363094
Interest coverage ratio: -0.9340879581288869
Free cash flow (dilution-adjusted): -1107990.909090909
Buyback yield (%): 0.5736681974508505
Retained earnings: -31905104.545454543
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.942979044758018
Rule of 40 score: 0
Financial ratios for WVM.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7703703703703704
Shares outstanding: 58075566
Market cap (USD): 44739695.28888889
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WVM.V — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.6643356643356644
Shares outstanding: 58075566
Market cap (USD): 38581669.72027972
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for WVM.V — annual report dated 2024-12-31
Total revenue: 0
Gross profit: -2380.4195804195806
Operating income: -643538.4615384616
Net income: -1801486.013986014
Capital expenditures: 0
Operating cash flow: -496165.73426573427
Depreciation & amortization: 2380.4195804195806
Net tangible assets: 29546786.713286713
Owner earnings: -1799105.5944055945
Return on net tangible assets (%): -6.089005927661724
Buffett classification: The Gruesome
Stock price: 0.6643356643356644
Shares outstanding: 58075566
Book value: 29611799.3006993
P/B ratio: 1.3029154131599356
Market cap (USD): 38581669.72027972
Debt to equity: 0
Current ratio: 15.667655118654421
Quick ratio: 15.667655118654421
Interest coverage ratio: -0.7641597406576727
Free cash flow (dilution-adjusted): -981706.2937062937
Buyback yield (%): 0
Retained earnings: -31252351.74825175
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.6616400007265817
Rule of 40 score: 0
Financial ratios for WVM.V — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -203148.95104895107
Net income: -405897.2027972028
Capital expenditures: 59378.32167832168
Operating cash flow: -144734.26573426573
Net tangible assets: 29156867.132867135
Owner earnings: -465275.5244755245
Return on net tangible assets (%): -1.5957665216748949
Buffett classification: The Gruesome
Stock price: 0.7832167832167833
Shares outstanding: 58075566
Book value: 29221820.979020976
P/B ratio: 1.5565682240908012
Market cap (USD): 45485757.98601399
Debt to equity: 0
Current ratio: 16.58808439157545
Quick ratio: 16.58808439157545
Interest coverage ratio: -0.8635231380195948
Free cash flow (dilution-adjusted): -269543.3566433567
Buyback yield (%): 0
Retained earnings: -31658248.95104895
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.5263410692230285
Rule of 40 score: 0
Financial ratios for WVM.V — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -209863.503649635
Net income: -59997.0802919708
Capital expenditures: 44622.62773722628
Operating cash flow: -167341.60583941604
Net tangible assets: 28508609.489051092
Owner earnings: -104619.70802919708
Return on net tangible assets (%): -0.36697583608690887
Buffett classification: The Gruesome
Stock price: 0.9781021897810219
Shares outstanding: 58075566
Book value: 28572951.09489051
P/B ratio: 1.9880284010121054
Market cap (USD): 56803838.27737226
Debt to equity: 0
Current ratio: 11.538850281985145
Quick ratio: 11.538850281985145
Interest coverage ratio: -0.8634179594827533
Free cash flow (dilution-adjusted): -272327.0072992701
Buyback yield (%): 0
Retained earnings: -33097237.956204377
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.550455820948781
Rule of 40 score: 0
Financial ratios for WVM.V — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -307936.69064748206
Net income: -682225.1798561151
Capital expenditures: 265807.91366906476
Operating cash flow: -135146.04316546762
Net tangible assets: 28214330.935251802
Owner earnings: -948033.0935251799
Return on net tangible assets (%): -3.360111908025719
Buffett classification: The Gruesome
Stock price: 1.431654676258993
Shares outstanding: 58075566
Book value: 28279038.848920867
P/B ratio: 2.9401337182809018
Market cap (USD): 83144155.64028779
Debt to equity: 0
Current ratio: 13.514540565747565
Quick ratio: 13.514540565747565
Interest coverage ratio: -1.257837386714939
Free cash flow (dilution-adjusted): -522712.9496402878
Buyback yield (%): 0
Retained earnings: -33287430.935251802
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.8057792644255943
Rule of 40 score: 0
Financial ratios for WVM.V — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -384772.99270072987
Net income: -494939.4160583941
Capital expenditures: 48372.99270072993
Operating cash flow: -97539.41605839416
Net tangible assets: 27764985.40145985
Owner earnings: -543312.4087591241
Return on net tangible assets (%): -1.956825839823987
Buffett classification: The Gruesome
Stock price: 1.846715328467153
Shares outstanding: 58075566
Book value: 27827137.956204377
P/B ratio: 3.8541167298771173
Market cap (USD): 107249037.94160582
Debt to equity: 0
Current ratio: 9.47942239334304
Quick ratio: 9.47942239334304
Interest coverage ratio: -1.4915454221346958
Free cash flow (dilution-adjusted): -387873.7226277372
Buyback yield (%): 0
Retained earnings: -33447347.445255473
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.0104260161136744
Rule of 40 score: 0
Financial ratios for WVM.V — annual report dated 2025-12-31
Total revenue: 0
Gross profit: -2535.766423357664
Operating income: -1095570.0729927006
Net income: -1647250.3649635036
Capital expenditures: 34607.29927007299
Operating cash flow: -553072.9927007299
Depreciation & amortization: 2535.766423357664
Net tangible assets: 27764985.40145985
Owner earnings: -1679321.8978102189
Return on net tangible assets (%): -6.0483442491632715
Buffett classification: The Gruesome
Stock price: 1.846715328467153
Shares outstanding: 58075566
Book value: 27827137.956204377
P/B ratio: 3.8541167298771173
Market cap (USD): 107249037.94160582
Debt to equity: 0
Current ratio: 9.47942239334304
Quick ratio: 9.47942239334304
Interest coverage ratio: -1.101099683079993
Free cash flow (dilution-adjusted): -1471892.7007299268
Buyback yield (%): 0
Retained earnings: -33447347.445255473
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -2.8770015703476948
Rule of 40 score: 0
Financial ratios for XOMA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.85
Shares outstanding: 17678742
Market cap (USD): 368601770.70000005
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XOMA — annual report dated 2022-12-31
Total revenue: 6027000
Operating income: -17414000
Net income: -17104000
Capital expenditures: 0
Operating cash flow: -12879000
Depreciation & amortization: 104000
Net tangible assets: 108864000
Owner earnings: -17000000
Return on net tangible assets (%): -15.615814226925337
Buffett classification: The Gruesome
Stock price: 18.4
Shares outstanding: 17678742
Book value: 124014000
P/B ratio: 2.6230010547196283
Market cap (USD): 325288852.79999995
Debt to equity: 0.0002741625945457771
Current ratio: 8.984012907010854
Quick ratio: 8.984012907010854
COGS to revenue (%): 0
R&D to revenue (%): 2.538576406172225
SG&A to revenue (%): 384.7851335656214
Free cash flow (dilution-adjusted): -31734000
Buyback yield (%): 0
Retained earnings: -1182392000
Receivables turnover: 2.546261089987326
Capitalized R&D asset: 153000
ROCI (R&D-adjusted, %): -12.946745739135638
FCF margin (%): -526.530612244898
Rule of 40 score: -526.530612244898
Financial ratios for XOMA — annual report dated 2023-12-31
Total revenue: 4758000
Operating income: -23463000
Net income: -40831000
Capital expenditures: 17000
Operating cash flow: -18158000
Depreciation & amortization: 900000
Net tangible assets: 88721000
Owner earnings: -39948000
Return on net tangible assets (%): -45.02654388476234
Buffett classification: The Gruesome
Stock price: 18.5
Shares outstanding: 17678742
Book value: 88721000
P/B ratio: 3.6863507737739654
Market cap (USD): 327056727
Debt to equity: 1.4027118720483314
Current ratio: 8.68316323914047
Quick ratio: 8.68316323914047
Interest coverage ratio: -41.23550087873462
COGS to revenue (%): 0
R&D to revenue (%): 3.0054644808743167
SG&A to revenue (%): 538.1672971836906
Free cash flow (dilution-adjusted): -27274000
Buyback yield (%): 0
Retained earnings: -1223223000
Receivables turnover: 0.31263552138773903
Capitalized R&D asset: 245510
ROCI (R&D-adjusted, %): -10.889996664768017
FCF margin (%): -573.2240437158471
Revenue growth (%): -21.05525136884022
Rule of 40 score: -594.2792950846873
Financial ratios for XOMA — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.48
Shares outstanding: 17678742
Market cap (USD): 468133088.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XOMA — quarterly report dated 2024-12-31
Capital expenditures: 3000
Buffett classification: The Gruesome
Stock price: 26.28
Shares outstanding: 17678742
Market cap (USD): 464597339.76
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for XOMA — annual report dated 2024-12-31
Total revenue: 10220000
Operating income: -39976000
Net income: -13821000
Capital expenditures: 20000
Operating cash flow: -13748000
Depreciation & amortization: 216000
Net tangible assets: 35993000
Owner earnings: -13625000
Return on net tangible assets (%): -37.85458283555136
Buffett classification: The Gruesome
Stock price: 26.28
Shares outstanding: 17678742
Book value: 61902000
P/B ratio: 7.5053688048851415
Market cap (USD): 464597339.76
Debt to equity: 1.9255920648767406
Current ratio: 5.153196028555017
Quick ratio: 5.153196028555017
Interest coverage ratio: -2.8884393063583813
COGS to revenue (%): 0
R&D to revenue (%): 28.131115459882583
SG&A to revenue (%): 337.3581213307241
Free cash flow (dilution-adjusted): -24080000
Buyback yield (%): 0.002798121919233436
Retained earnings: -1237057000
Receivables turnover: 0.6006464883925948
Capitalized R&D asset: 3021300
ROCI (R&D-adjusted, %): -19.086224135835415
FCF margin (%): -235.6164383561644
Revenue growth (%): 114.79613282891972
Rule of 40 score: -120.82030552724467
Financial ratios for XOMA — quarterly report dated 2025-03-31
Total revenue: 4317000
Operating income: 5929000
Net income: 2367000
Capital expenditures: 0
Operating cash flow: 2198000
Depreciation & amortization: 547000
Net tangible assets: 59264000
Owner earnings: 2914000
Return on net tangible assets (%): 4.916981641468682
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 19.93
P/E ratio: 37.21349050063372
Shares outstanding: 17678742
Book value: 84629000
P/B ratio: 4.163316688841887
Market cap (USD): 352337328.06
Debt to equity: 1.3523969324935896
Current ratio: 5.541010081237154
Quick ratio: 5.541010081237154
Effective tax rate (%): 0
Interest coverage ratio: 1.7101240265359101
COGS to revenue (%): 0
R&D to revenue (%): 29.951355107713688
SG&A to revenue (%): 188.69585360203845
Free cash flow (dilution-adjusted): 215000
Buyback yield (%): 0.15468131151496703
Retained earnings: -1235235000
Receivables turnover: 0.23723690718250262
Capitalized R&D asset: 1293000
ROCI (R&D-adjusted, %): 3.5075848746700826
FCF margin (%): 4.9803104007412555
Rule of 40 score: 4.9803104007412555
Financial ratios for XOMA — quarterly report dated 2025-06-30
Total revenue: 5379000
Operating income: 4603000
Net income: 9191000
Capital expenditures: 0
Operating cash flow: 6470000
Depreciation & amortization: 658000
Net tangible assets: 47020000
Owner earnings: 9849000
Return on net tangible assets (%): 20.946405784772438
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 25.2
P/E ratio: 38.54510282055719
Shares outstanding: 17678742
Book value: 92454000
P/B ratio: 4.818658991498475
Market cap (USD): 445504298.4
Debt to equity: 1.2393514612672247
Current ratio: 4.881367759944173
Quick ratio: 4.881367759944173
Interest coverage ratio: 1.422435105067985
COGS to revenue (%): 0
R&D to revenue (%): 1.2827663134411602
SG&A to revenue (%): 145.04554749953522
Free cash flow (dilution-adjusted): -15749000
Buyback yield (%): 0.409648123835027
Retained earnings: -1227892000
Receivables turnover: 0.2626849636177174
Capitalized R&D asset: 935310
ROCI (R&D-adjusted, %): 2.0788943869900836
FCF margin (%): -292.78676333891053
Revenue growth (%): 24.600416956219597
Rule of 40 score: -268.18634638269094
Financial ratios for XOMA — quarterly report dated 2025-09-30
Total revenue: 532000
Operating income: -1330000
Net income: 14051000
Capital expenditures: 0
Operating cash flow: -296000
Depreciation & amortization: 880000
Net tangible assets: 63401000
Owner earnings: 14931000
Return on net tangible assets (%): 23.550101733411143
Buffett classification: The Gruesome
Stock price: 38.54
P/E ratio: 26.60544014526143
Shares outstanding: 17678742
Book value: 107957000
P/B ratio: 6.311204615541373
Market cap (USD): 681338716.68
Debt to equity: 1.221903165149087
Current ratio: 3.9112170994523936
Quick ratio: 3.9112170994523936
Effective tax rate (%): 0.3475177304964539
Interest coverage ratio: -0.4029082096334444
COGS to revenue (%): 0
R&D to revenue (%): 12.969924812030076
SG&A to revenue (%): 1829.6992481203006
Free cash flow (dilution-adjusted): -2177000
Buyback yield (%): 0.0036692469381189724
Retained earnings: -1213866000
Receivables turnover: 0.029985345507834518
Capitalized R&D asset: 541920
ROCI (R&D-adjusted, %): -0.7383556471377121
FCF margin (%): -409.2105263157895
Revenue growth (%): -90.10968581520729
Rule of 40 score: -499.32021213099677
Financial ratios for XOMA — annual report dated 2025-12-31
Total revenue: 11660000
Operating income: 11384000
Net income: 31712000
Capital expenditures: 0
Operating cash flow: 2871000
Depreciation & amortization: 2972000
Net tangible assets: 39185000
Owner earnings: 34684000
Return on net tangible assets (%): 88.51346178384586
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 26.59
P/E ratio: 14.823339738269425
Shares outstanding: 17678742
Book value: 83941000
P/B ratio: 5.60009708938421
Market cap (USD): 470077749.78
Debt to equity: 1.567231746107385
Current ratio: 3.3675761056863873
Quick ratio: 3.3675761056863873
Effective tax rate (%): 0.32374666038032374
Interest coverage ratio: 0.8736090860256311
COGS to revenue (%): 0
R&D to revenue (%): 14.682675814751287
SG&A to revenue (%): 309.5368782161235
Free cash flow (dilution-adjusted): -27127000
Buyback yield (%): 3.5557947611480762
Retained earnings: -1221450000
Receivables turnover: 0.42130365659777425
Capitalized R&D asset: 3685440
ROCI (R&D-adjusted, %): 4.768657597082296
FCF margin (%): -232.6500857632933
Revenue growth (%): 14.090019569471623
Rule of 40 score: -218.56006619382168